Cellebrite DI Ltd.
CLBT
Positions held
Your positionsCLBT isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Cellebrite operates in a growing sector of software infrastructure, which is increasingly essential for digital investigations and data security.
- Revenue increased by 2% compared to the prior quarter, reaching $131 million.
- The company maintains a strong gross margin of 80.8%, although it has slightly decreased from the previous quarter.
- Cellebrite faces significant competition in the software infrastructure industry, which may impact its market share and pricing power.
- The company reported a net income loss of $81.1 million in 2023, indicating financial challenges.
- The stock has a 'Sell' signal with a score of -13.00, reflecting negative trends in its performance metrics.
Fundamentals
| Market cap | $2.85B | Enterprise value | $2.42B | Trailing P/E | 49.30 | Forward P/E | 17.36 |
| PEG | — | Price / book | 5.28 | Beta | 1.13 | Dividend yield | 0.00% |
| Revenue growth | 15.8% | Earnings growth | -67.9% | Gross margin | 83.0% | Operating margin | 5.3% |
| Profit margin | 11.4% | ROE | 12.4% | ROA | 3.9% | Debt / equity | 0.04 |
| Current ratio | 1.62 | Free cash flow | $124.92M | Analyst recommendation | none | Mean target | $15.36 |
| 52w high | $19.98 | 52w low | $9.58 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $131M | $128M | $129M | $126M | $113M | — |
| Op margin | 5.3% | 7.1% | 16.2% | 15.1% | 12.7% | — |
| Net income | $6.4M | $10.9M | $21.3M | $20.2M | $19.5M | — |
| Gross margin | 80.8% | 82.5% | 84.7% | 83.9% | 84.4% | — |
| Gross profit | $106M | $106M | $109M | $106M | $95.6M | — |
| Operating income | $6.9M | $9.1M | $20.8M | $19.0M | $14.4M | — |
- Revenue +2% vs prior quarter ($131M vs $128M).
- Gross margin 80.8% (was 82.5% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $476M | $401M | $325M | $271M | — |
| Op margin | 14.0% | 14.2% | 10.2% | 0.4% | — |
| Net income | $78.3M | -$283M | -$81.1M | $121M | — |
| Gross margin | 84.2% | 84.4% | 83.6% | 81.3% | — |
| Gross profit | $401M | $339M | $272M | $220M | — |
| Operating income | $66.5M | $56.9M | $33.2M | $1.0M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · 3 US Growth Tech Stocks Retail Investors Are Watching After Cooling Inflation
2026-09-29 · Cellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound
2026-09-23 · Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe
2026-09-23 · Twilio (TWLO) Surges 6.9%: Is This an Indication of Further Gains?
2026-09-22 · Is Cellebrite DI (CLBT) A Bargain On Its Subscription Growth Narrative?
2026-09-21 · 3 AML Tech Stocks Investors May Want To Watch After Money Laundering Headlines
2026-09-17 · Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals
2026-09-17 · Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals
2026-09-17 · Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals
2026-09-14 · Cellebrite DI Plans to Redomicile in US
2026-09-14 · Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research
2026-09-14 · Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research
Price (daily)
Full chart · RSI · MACD · patterns